Clinical Trials Browser

NETWORK × Colorectal Neoplasms × Vemurafenib × Clear all

NCT02164916 2020-12-30

S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer

Phase 2 Completed

106 enrolled 16 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms